• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 376
  • 73
  • 60
  • 36
  • 30
  • 12
  • 9
  • 8
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • Tagged with
  • 789
  • 789
  • 101
  • 101
  • 84
  • 79
  • 78
  • 77
  • 76
  • 70
  • 68
  • 60
  • 58
  • 57
  • 55
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
231

Enzyme replacement therapy in a feline model of mucopolysaccharidosis type VI / Allison Catherine Crawley.

Crawley, Allison Catherine January 1998 (has links)
Bibliography: leaves 269-297. / xvii, 297, [10] leaves, [31] leaves of plates : ill. (some col.) ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Evaluates the efficacy of enzyme replacement therapy (ERT) with artifically produced recombinant human 4S (rh4S) in feline mucopolysaccharidosis Type VI (MPS VI) and tests the hypothesis that this form of therapy would reverse or alter the disease course, particularly the bone dysplasia and connective tissue pathologics. / Thesis (Ph.D.)--University of Adelaide, Dept. of Paediatrics, 1998
232

Gene Therapy For Glioblastoma Multiforme: A Novel Treatment For A Fatal Disease

Teong Lip Chuah Unknown Date (has links)
Gliomas are the commonest primary tumours of the brain and glioblastoma multiforme (GBM) represents more than 50% of this group. GBM remains a neurosurgical conundrum since patients often succumb to the disease within one year. Surgery followed by radiation and medical regimens over the years have had minimal impact on the prognosis of patients with this cancer and hence, alternative and novel therapeutic modalities are required if the survival of patients with this disease is to be significantly improved. The ATM gene, which is mutated in the disease ataxia-telangiectasia (A-T), is implicated in response to radiation-induced DNA damage, leading to profound radiosensitivity. By reducing the levels of ATM in the radioresistant GBM cells through antisense or RNA interference (RNAi) technology delivered by lentiviruses, malignant GBM tumour cells were successfully sensitised to radiation treatment. In conjunction with surgery, this strategy will provide an enhanced therapeutic intervention especially in the case of GBM where the tumour is untreatable. In this thesis, analysis of the D-3-Phosphoglycerate dehydrogenase promoter in a GBM cell line as well as the development of a novel rat model for GBM using a bioluminescent F98 cell line will also be presented.
233

A lentiviral gene transfer vector for the treatment of cystic fibrosis airway disease / Maria Limberis.

Limberis, Maria January 2002 (has links)
"16th September 2002." / Accompanying CD contains 2 MPEG clips with accompanying text, and a copy in PDF format of: Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer / M. Limberis ... [et al.], published in Human gene therapy vol. 13 (2002). / Bibliography: leaves xxix-li. / xxvii, 213, li leaves : ill., plates (some col.) ; 30 cm. + 1 CD-ROM (4 3/4 in.) / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / This thesis focuses on modulating the physical barriers of the airway epithelium with mild detergents, so as to enhance gene transfer by a HIV-1 based lentivirus vector in vivo. The efficiency of the gene transfer was evaluated in the nasal airway of C57B1/6 mice using the Lac Z marker gene. This demonstration of lentivirus-mediated in vivo recovery of CFTR function in CF airway epithelium illustrated the potential of combining a pre-conditioning of the airway surface with a simple and brief HIV-1 based gene transfer vector exposure to produce therapeutic gene expression in the intact airway. / Thesis (Ph.D.)--University of Adelaide, Dept. of Paediatrics, 2003
234

The application of gene therapy to flap preservation

Roman, Sandrine, Medical Sciences, Faculty of Medicine, UNSW January 2008 (has links)
Reconstructive flaps are a mainstay form of treatment for anatomical defects in plastic surgery, and despite extensive progress in the areas of flap anatomy and design, the mechanism of flap healing and the factors that regulate this process are poorly understood. This thesis investigates the regulation of flap healing, and tests the hypothesis that the introduction of genes for angiogenic growth factors can be used to augment the vascularisation and wound healing of ischaemic flaps. Using a modified McFarlane ischaemic skin flap model in Sprague Dawley rats, endogenous angiogenic regulatory factors that included the VEGF and angiopoietin families and their receptors were investigated. Twelve specific quantitative real-time PCR assays documented a general up-regulation of angiogenic genes and their receptors with time following flap elevation. There was not a readily identifiable “master regulator”. Angiogenic protein levels were more variable with a decrease VEGF-A and TNF-α levels along the flap. Debridement studies of the necrotic distal flaps demonstrated for the first time that VEGF-A164 and TNF-α protein levels stabilised, while angiogenic genes of VEGF-A164, VEGF-A120, angiopoietins and their receptors were down-regulated and VEGF-B186 and HIF-1α mRNA increased, compared to non-debrided flaps. Leucocyte proteolysis in devitalised tissue is discussed as a possible mechanism for reduced angiogenic proteins levels in ischaemic flaps. The impact of angiogenic gene therapy using adenoviral vectors in the flap model revealed for the first time that recombinant adenoviruses containing the VEGF-B186 transgene could significantly augment neovascularisation and improve flap survival. This neovascularisation correlated with up-regulation of the expression of multiple endogenous angiogenic genes that included VEGF-A164, the angiopoietins and their receptors. Erythematous plaques were documented as a side effect of Ad VEGF-A165 and Ad VEGF-B186 treatment of rat skin, although in the latter treatment they were very mild. Weals induced by the presence of VEGF-A165 transgene were associated with a marked acute inflammatory cell infiltrate and oedema consistent with the increased vascular permeability effects of VEGF-A165. Ad VEGF-A165 plus Ad ANG-1* induced weals were less prominent with reduced oedema highlighting the stabilising effect of Ad ANG-1* on vascular permeability.
235

Produktsicherheit bei Erforschung somatischer Gentherapie

Voss, Levke January 2005 (has links)
Zugl.: Düsseldorf, Univ., Diss., 2005
236

The development of synthetic gene delivery systems /

Brandén, Lars J., January 1900 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2001. / Härtill 5 uppsatser.
237

A gene transfer system derived from human immunodeficiency virus type 1 (HIV-1) /

Fuller, Maria. January 2001 (has links) (PDF)
Thesis (Ph.D.)--University of Adelaide, Dept. of Public Health, 2002. / Bibliography: p. 189-229.
238

Diabetes : a gene therapy approach using genetically modified skin cells /

Facey, Sandra Lee. January 2004 (has links)
Thesis (M.Sc. (Hons.)) -- University of Western Sydney, 2004. / Bibliography : leaves 61 - 68.
239

Chosen children? : an empirical study and a philosophical analysis of moral aspects of pre-implantation genetic diagnosis and germ-line gene theraphy /

Zeiler, Kristin, January 2005 (has links)
Diss. Linköping : Linköpings universitet, 2005.
240

DNA-LPEI complexes encapsulated in LTP nanospheres as a non-viral gene therapy vector

Ditto, Andrew. January 2006 (has links)
Thesis (M.S.)--University of Akron, Dept. of Biomedical Engineering, 2006. / "December, 2006." Title from electronic thesis title page (viewed 12/31/2008) Advisor, Yang Yun; Committee members, Stephanie Lopina, Steven Schmidt; Department Chair, Daniel Sheffer; Dean of the College, George K. Haritos; Dean of the Graduate School, George R. Newkome. Includes bibliographical references.

Page generated in 0.0499 seconds